Rapamycin decreased accumulation of Aβ and Tau leading to decreased loss of neurons, attenuated neuroinflammation and alleviated cognitive dysfunction in mouse models of Alzheimer’s disease [221]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.